Literature DB >> 18274559

Treatment strategies for allergy and asthma.

Stephen T Holgate1, Riccardo Polosa.   

Abstract

Allergic diseases have reached epidemic proportions worldwide. An understanding of the cellular and soluble mediators that are involved in allergic inflammatory responses not only helps in understanding the mechanisms of current treatments, but is also important for the identification of new targets that are amenable to both small-molecule and biological interventions. There is now considerable optimism with regards to tackling the allergy epidemic in light of improvements in systemic and mucosal allergen-specific immunotherapy, the identification of key cytokines and their receptors that drive T-helper-2-cell polarization, a clearer understanding of the pathways of leukocyte recruitment and the signalling pathways that are involved in cell activation and mediator secretion, and new approaches to vaccine development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18274559     DOI: 10.1038/nri2262

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  180 in total

Review 1.  Emerging roles of T helper subsets in the pathogenesis of asthma.

Authors:  Douglas M Durrant; Dennis W Metzger
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

2.  Increased nicotinamide adenine dinucleotide phosphate oxidase 4 expression mediates intrinsic airway smooth muscle hypercontractility in asthma.

Authors:  Amanda Sutcliffe; Fay Hollins; Edith Gomez; Ruth Saunders; Camille Doe; Marcus Cooke; R A John Challiss; Chris E Brightling
Journal:  Am J Respir Crit Care Med       Date:  2011-11-22       Impact factor: 21.405

3.  Regulatory T cells and regulation of allergic airway disease.

Authors:  Helen Martin; Christian Taube
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

4.  Glycomacropeptide administration attenuates airway inflammation and remodeling associated to allergic asthma in rat.

Authors:  Nuria Renata Roldán; Mariela Jiménez; Daniel Cervantes-García; Estefanía Marín; Eva Salinas
Journal:  Inflamm Res       Date:  2016-01-11       Impact factor: 4.575

5.  Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways.

Authors:  David F Choy; Barmak Modrek; Alexander R Abbas; Sarah Kummerfeld; Hilary F Clark; Lawren C Wu; Grazyna Fedorowicz; Zora Modrusan; John V Fahy; Prescott G Woodruff; Joseph R Arron
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

6.  CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen.

Authors:  Shiteng Duan; Cynthia J Koziol-White; William F Jester; Scott A Smith; Corwin M Nycholat; Matthew S Macauley; Reynold A Panettieri; James C Paulson
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

7.  Tripterygium polyglycosid attenuates the established airway inflammation in asthmatic mice.

Authors:  Chang-Gui Chen; Hui-Ying Wang; Yu Dai; Jiao-Li Wang; Wei-Hua Xu
Journal:  Chin J Integr Med       Date:  2013-01-15       Impact factor: 1.978

8.  From allergen to oral vaccine carrier: A new face of ragweed pollen.

Authors:  Md Jasim Uddin; Harvinder Singh Gill
Journal:  Int J Pharm       Date:  2018-05-03       Impact factor: 5.875

9.  Enhanced generation of suppressor T cells in patients with asthma taking oral contraceptives.

Authors:  A Catalina Vélez-Ortega; James Temprano; Mary Catherine Reneer; Gavin I Ellis; Andrea McCool; Tonya Gardner; Mehdi Khosravi; Francesc Marti
Journal:  J Asthma       Date:  2013-02-05       Impact factor: 2.515

10.  Finding better therapeutic targets for patients with asthma: adenosine receptors?

Authors:  R Polosa
Journal:  Br J Pharmacol       Date:  2008-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.